Quantitative Preferences for Lung Cancer Treatment from the Patients' Perspective: A Systematic Review.

The Patient
Yasuo SugitaniShunsuke Ono

Abstract

Regulatory agencies as well as private organizations pursue programs that advocate patient centricity and emphasize the importance of dialog with patients. Various methods are applied to elicit the preferences of patients regarding the aspects of treatment they lend more importance to. Decisions on treatment choices are critical to patients with lung cancer because of their poor prognosis and the serious trade-off between safety and efficacy in traditional cytotoxic chemotherapy. We conducted a systematic literature review of quantitative patient preference studies of patients with lung cancer. Our exhaustive search of MEDLINE, CINAHL, EMBASE, PLOS, and SpringerLink identified 15 relevant studies published from January 2000 to April 2020 that enabled us to assess the relative importance of treatment attributes according to lung cancer patients' perspective. The literature review revealed that patients with lung cancer tend to place a higher weight on efficacy and quality of life (QoL) attributes than on other attributes. Overall survival was found to be the most important among the efficacy attributes. The consequences of adverse events seemed less important than the possible efficacy from therapies. The clinical utility of tre...Continue Reading

References

Dec 4, 2003·Psychosomatic Medicine·Michael Von KorffTerry Bush
May 19, 2005·International Journal of Cancer. Journal International Du Cancer·Susan S DevesaD Max Parkin
Dec 7, 2007·Postgraduate Medical Journal·A N HopperW G Lewis
Oct 23, 2008·Health and Quality of Life Outcomes·Beenish NafeesJessamy Watkins
Apr 14, 2009·Clinical Lung Cancer·Carlos CampsRafael Sirera
Jul 28, 2009·Journal of Clinical Epidemiology·David MoherUNKNOWN PRISMA Group
Dec 19, 2009·American Journal of Respiratory and Critical Care Medicine·Sandra R WilsonUNKNOWN Better Outcomes of Asthma Treatment (BOAT) Study Group
Jun 24, 2010·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Prunella BlinmanMartin R Stockler
Sep 8, 2010·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Prunella BlinmanMartin R Stockler
Jun 15, 2011·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·John F P BridgesJosephine Mauskopf
Mar 1, 2012·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·John F P BridgesA Brett Hauber
Mar 1, 2012·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Regina GironésRafael Rosell
Aug 20, 2014·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Axel C Mühlbacher, Susanne Bethge
Sep 16, 2014·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayFreddie Bray
Jun 24, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lowell E Schnipper American Society of Clinical Oncology
Sep 14, 2016·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·L J FallowfieldV A Jenkins
Sep 14, 2016·The Annals of Thoracic Surgery·Betty C TongJoel C Huber
Oct 9, 2016·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Margot LehmanJennifer Whitty
Aug 15, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nasser HannaGregory Masters
Oct 17, 2017·Patient Preference and Adherence·Katharina SchmidtJ-Matthias Graf von der Schulenburg
Apr 24, 2018·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Matjaz Zwitter
May 31, 2018·The Patient·Juan Marcos GonzalezHolly Peay
Nov 6, 2018·PharmacoEconomics·Vikas SoekhaiCaroline M Vass
Apr 28, 2019·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Donald R SullivanChristopher G Slatore
Sep 29, 2019·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·V ValentíR Salazar
Oct 1, 2018·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D PlanchardUNKNOWN ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.